Michael Kolodziej, MD, national medical director for oncology strategy at Aetna, said that the evaluation of academic medical centers has allowed the company to examine what lies at the heart of creating optimal patient outcomes and experiences.
Michael Kolodziej, MD, national medical director for oncology strategy at Aetna, said that the evaluation of academic medical centers has allowed the company to examine what lies at the heart of creating optimal patient outcomes and experiences.
Transcript (slightly modified)
Is Aetna evaluating payment pilot programs in the community oncology setting? And how has the response there been different from cancer centers?
So as many of your viewers know, we’re very actively engaged with predominantly community oncology programs. Our engagement is everything from the implementation of clinical pathways programs—which are typically on a geographic basis—to more intimate and collegiate relationships around enhanced care delivery, which we’ve called the “Oncology Medical Home” for lack of a better term. And we’ve been doing that really now for several years. We do have some data, and people internal to Aetna are quite excited about the results. We’ve even cut practices some checks around their performance.
Academic medical centers are a different beast and they’re a much more complicated and potentially untapped area for looking at care delivery or form and improving processes of care. So we have initiated efforts with Moffat Cancer Center and University of Chicago; we have a number of other academic centers that we’re engaging. That’s a really different delivery model, right? They’re comprehensive typically, they offer all clinical services, and they really do have a different care model.
It’s not better or worse than a community model, it’s just different and the opportunities, therefore, are quite different. I can start to ask really, really different questions about, for example, surgical oncology which is very hard to answer in the community setting. I can answer questions about coordination of care, I can answer questions about aggressively implementing palliative care services because these hospitals have palliative care services. Most community practices do not so it’s a different relationship, it’s a different business deal, but it does get to the heart of looking at the optimal patient experience and optimal patient outcome.
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More